Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in marginalized populations, and interventions on social determinants of health, such as food insecurity. He has an additional interest in racism and health care, particularly its manifestations in medical education and training.
Diversity, Equity, Inclusion and Accessibility
My Diversity/Equity Inclusion work has taken several forms:
I have worked to explore the role of racism in health professions admissions and in medical education. I and my colleagues have written several papers on bias due to race, gender, and other factors during the interview process to medical school and other health profession programs. While at Harvard Medical School, I was the faculty advisor for the Racial Justice Coalition and in that role, worked to expand and improve the curriculum with regard to its discussion of racism in health care. As part of that role, I have mentored several students in writing papers describing these efforts.
Secondly, I have worked to explore the role of racism in the conceptualization and treatment of addiction in the United States. In my role on the Healing Communities Study, I helped found the Racial Equity and Social Justice committee, which works to improve efforts to incorporate intentional efforts to promote equity in addiction treatment. We describe our work in a paper in the American Journal of Public Health, but the racial equity work we are undertaking is ongoing.
I serve in several committee roles at BMC and in national organizations. I serve on the Boston University Medical Group (BUMG) Diversity and Inclusion Advisory Council, as well as the Section of General Internal Medicine's Anti-Racism committee. I also serve on AMERSA's Diversity Committee. In that role, I am leading a subcommittee that is developing a bibliography of papers on other resources examining the role of racism in addiction treatment.
Evans Center for Interdisciplinary Biomedical Research
Boston University Chobanian & Avedisian School of Medicine
Clinical Addiction Research and Education Unit
Evaluation of the Community Care in Reach(R) Mobile Addictio
12/01/2021 - 11/30/2022 (PI)
Massachusetts General Hospital
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 35 results.
Adams JW, Savinkina A, Fox A, Behrends CN, Madushani RWMA, Wang J, Chatterjee A, Walley AY, Barocas JA, Linas BP. Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs. Addiction. 2022 Oct; 117(10):2635-2648.View Related Profiles. PMID: 35315148
Swartz N, Adnan T, Peréa F, Baggett TP, Chatterjee A. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness. J Subst Abuse Treat. 2022 Jul; 138:108752. PMID: 35277306
Noyes EA, Dunleavy S, Mail V, Plakas I, Keyes S, Gaeta JM, Obando A, Paci E, Lent C, Regis C, Taveras EM, Yule AM, Chatterjee A. Awareness, Utilization, and Preferences of Harm Reduction Interventions among Street-Involved Young Adults in Boston. Subst Use Misuse. 2022; 57(5):827-832.View Related Profiles. PMID: 35195488
Chatterjee A, Glasgow L, Bullard M, Sabir M, Hamilton G, Chassler D, Stevens-Watkins DJ, Goddard-Eckrich D, Rodgers E, Chaya J, Rodriguez S, Gutnick DN, Oga EA, Salsberry P, Martinez LS. Placing Racial Equity at the Center of Substance Use Research: Lessons From the HEALing Communities Study. Am J Public Health. 2022 02; 112(2):204-208. PMID: 35080947; DOI: 10.2105/AJPH.2021.306572;
Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Kumar A, Linas BP, Morgan JR, Murphy SM, Walley AY, Yan S, Schackman BR, Marshall BDL. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 2022 May; 117(5):1372-1381.View Related Profiles. PMID: 34825427; DOI: 10.1111/add.15759;
Sandoval RS, Dunleavy S, Afolabi T, Said JT, Connor J, Hossain A, Kassamali B, Kienka T, Srinivasan M, Cheng A, Ölveczky D, Chatterjee A. Equity in medical education: Addressing microaggressions and discrimination on the wards. Med Teach. 2022 May; 44(5):551-558. PMID: 34860635
Chatterjee A, Yan S, Xuan Z, Waye KM, Lambert AM, Green TC, Stopka TJ, Pollini RA, Morgan JR, Walley AY. Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts. Drug Alcohol Depend. 2022 01 01; 230:109190.View Related Profiles. PMID: 34864356; DOI: 10.1016/j.drugalcdep.2021.109190;
Afolabi T, Borowsky HM, Cordero DM, Paul DW, Said JT, Sandoval RS, Davis D, Ölveczky D, Chatterjee A. Student-Led Efforts to Advance Anti-Racist Medical Education. Acad Med. 2021 06 01; 96(6):802-807. PMID: 33711839
Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J, Linas BP, Assoumou SA. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug Alcohol Depend. 2021 08 01; 225:108764.View Related Profiles. PMID: 34051547; DOI: 10.1016/j.drugalcdep.2021.108764;
McLaughlin MF, Li R, Carrero ND, Bain PA, Chatterjee A. Opioid use disorder treatment for people experiencing homelessness: A scoping review. Drug Alcohol Depend. 2021 07 01; 224:108717. PMID: 33985863; DOI: 10.1016/j.drugalcdep.2021.108717;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.